Jun Hou
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Cancer Research top 5%
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Hepatitis C virus research 5
-
- Parasitic infections in humans and animals 9
- Co-authors
- Yingying Ding (7 shared papers)Shunquan Wu (7 shared papers)Fuquan Wu (6 shared papers)Panyong Mao (9 shared papers)Jingfeng Bi (3 shared papers)Frank G. Grosveld (5 shared papers)Sjaak Philipsen (4 shared papers)André Boonstra (12 shared papers)
- Journals
- Scientific Reports (7 papers)Oncotarget (5 papers)PLoS ONE (4 papers)Acta Biochimica et Biophysica Sinica (4 papers)BMC Cancer (3 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Jun Hou
125 papers receiving 4.7k citations
Jun Hou's Hit Papers
Peers
Comparison fields: 5 of 135
- Hepatology 338
- Cancer Research 347
- Oncology 571
- Biological Psychiatry 22
- Pulmonary and Respiratory Medicine 500
Countries citing papers authored by Jun Hou
This map shows the geographic impact of Jun Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Hou more than expected).
Fields of papers citing papers by Jun Hou
This network shows the impact of papers produced by Jun Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Hou. The network helps show where Jun Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction Hit paper breakdown → | 2010 | 638 |
| 2 | 2016 | 278 | |
| 3 | Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China Hit paper breakdown → | 2015 | 271 |
| 4 | 2016 | 175 | |
| 5 | 2015 | 129 | |
| 6 | 2014 | 128 | |
| 7 | 2015 | 123 | |
| 8 | 2015 | 103 | |
| 9 | 2015 | 102 | |
| 10 | 2017 | 100 | |
| 11 | 2015 | 89 | |
| 12 | 2018 | 87 | |
| 13 | 2008 | 77 | |
| 14 | Monascus pigment-protected bone marrow-derived stem cells for heart failure treatment Hit paper breakdown → | 2024 | 72 |
| 15 | 2018 | 71 | |
| 16 | 2019 | 71 | |
| 17 | 2015 | 69 | |
| 18 | 2016 | 68 | |
| 19 | 2019 | 67 | |
| 20 | 2012 | 66 |
About Jun Hou
Jun Hou is a scholar working on Hepatology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 128 papers that have together received 4.8k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (10 papers), Hepatitis B Virus Studies (9 papers), Parasitic infections in humans and animals (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Immune Cell Function and Interaction (6 papers), Renal cell carcinoma treatment (6 papers), Hepatitis C virus research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Hepatology (338 citations), Cancer Research (347 citations), Oncology (571 citations), Biological Psychiatry (22 citations) and Pulmonary and Respiratory Medicine (500 citations). Jun Hou has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yingying Ding, Shunquan Wu, Fuquan Wu, Panyong Mao, Jingfeng Bi, Frank G. Grosveld, Sjaak Philipsen, André Boonstra, Wilfred F. J. van IJcken and Joachim G.J.V. Aerts. Their work appears in journals such as Scientific Reports, Oncotarget, PLoS ONE, Acta Biochimica et Biophysica Sinica and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.